Related references
Note: Only part of the references are listed.Multiplexed electrospray enables high throughput production of cGAMP microparticles to serve as an adjuvant for a broadly acting influenza vaccine
Cole J. Batty et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Induction of broadly reactive influenza antibodies increases susceptibility to autoimmun ity
Jocelyn G. Labombarde et al.
CELL REPORTS (2022)
STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant
Matthew D. Gallovic et al.
JOURNAL OF CONTROLLED RELEASE (2022)
A predictive mechanistic model of drug release from surface eroding polymeric nanoparticles
Rebeca T. Stiepel et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Next Generation of Computationally Optimized Broadly Reactive HA Vaccines Elicited Cross-Reactive Immune Responses and Provided Protection against H1N1 Virus Infection
Ying Huang et al.
VACCINES (2021)
Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination
Carolyn M. Boudreau et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin
Giuseppe A. Sautto et al.
JOURNAL OF IMMUNOLOGY (2020)
N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies
Ying Huang et al.
JOURNAL OF VIROLOGY (2020)
Autoreactivity of Broadly Neutralizing Influenza Human Antibodies to Human Tissues and Human Proteins
Surender Khurana et al.
VIRUSES-BASEL (2020)
Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral Immunity
Gillie A. Roth et al.
ACS CENTRAL SCIENCE (2020)
Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance
Kimberly M. Cirelli et al.
CELL (2019)
A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity
Rebekah Watkins-Schulz et al.
BIOMATERIALS (2019)
Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity
James T. Earnest et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization
Felicity C. Stark et al.
VACCINE (2019)
A Sample-Sparing Multiplexed ADCP Assay
Audrey L. Butler et al.
FRONTIERS IN IMMUNOLOGY (2019)
Electrospray for generation of drug delivery and vaccine particles applied in vitro and in vivo
Rebeca T. Steipel et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Goran Bajic et al.
SCIENTIFIC REPORTS (2019)
Extracting the barbs from complement assays: Identification and optimisation of a safe substitute for traditional buffers
Wioleta M. Zelek et al.
IMMUNOBIOLOGY (2018)
A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination
Robert D. Junkins et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Towards a universal influenza vaccine: different approaches for one goal
Giuseppe A. Sautto et al.
VIROLOGY JOURNAL (2018)
Investigation of tunable acetalated dextran microparticle platform to optimize M2e-based influenza vaccine efficacy
Naihan Chen et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses
James D. Allen et al.
PLOS ONE (2018)
Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine
Liudmila M. Tsybalova et al.
PLOS ONE (2018)
Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists
Michael A. Collier et al.
MOLECULAR PHARMACEUTICS (2018)
Degradation of acetalated dextran can be broadly tuned based on cyclic acetal coverage and molecular weight
Naihan Chen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic
Le Nguyen Minh Hoa et al.
JOURNAL OF VIROLOGY (2016)
Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses
Donald M. Carter et al.
JOURNAL OF VIROLOGY (2016)
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies
Edward A. Belongia et al.
LANCET INFECTIOUS DISEASES (2016)
Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
Hok Hei Tam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity
Robert A. Mitchell et al.
SCIENTIFIC REPORTS (2016)
Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant
Vladimir Beljanski et al.
JOURNAL OF VIROLOGY (2015)
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
Antonietta Impagliazzo et al.
SCIENCE (2015)
Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers
Woo Jung Kim et al.
VACCINE (2015)
Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus
Wenqian Tao et al.
NANOMEDICINE (2014)
Electrospray Encapsulation of Toll-Like Receptor Agonist Resiquimod in Polymer Microparticles for the Treatment of Visceral Leishmaniasis
Anthony D. Duong et al.
MOLECULAR PHARMACEUTICS (2013)
Efficient Delivery of the Toll-like Receptor Agonists Polyinosinic:Polycytidylic Acid and CpG to Macrophages by Acetalated Dextran Microparticles
Kevin J. Peine et al.
MOLECULAR PHARMACEUTICS (2013)
The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect
Samuele Calabro et al.
VACCINE (2013)
Synthesis and Characterization of Acetalated Dextran Polymer and Microparticles with Ethanol as a Degradation Product
Kevin J. Kauffman et al.
ACS APPLIED MATERIALS & INTERFACES (2012)
AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland
Hanna Nohynek et al.
PLOS ONE (2012)
Serologic assays for influenza surveillance, diagnosis and vaccine evaluation
Jacqueline M. Katz et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
The 2009 H1N1 influenza outbreak in its historical context
Derek Gatherer
JOURNAL OF CLINICAL VIROLOGY (2009)
Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza
Gerardo Chowell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy
Kyle E. Broaders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells
Ding Yuan Oh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection
Laura Bungener et al.
VACCINE (2008)
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Noelle-Angelique M. Molinari et al.
VACCINE (2007)
FcγRIV:: A novel FcR with distinct IgG subclass specificity
F Nimmerjahn et al.
IMMUNITY (2005)
Share Paper
